2. Cholinergics & anticholinergics Flashcards
Types of cholinergic receptors
1. Muscarinic: M1: stomach, CNS (nausea and vomiting pathways) M2: heart, CNS M3: lungs, glands, GI tract, CNS M4, M5: CNS
- Nicotinic:
N1 or Nm: skeletal muscle
N2 or Nn: ganglion, CNS
Common adverse effects of cholinergic agonists
diarrhoea, diaphoresis, miosis, nausea, urinary urgency
General contraindications of cholinergic drugs
- asthma (they cause bronchoconstriction)
2. peptic ulcer (they enhance gastric acid secretion)
Types of direct cholinergic drugs
Muscarinic: pilocarpine, bethanechol
Nicotinic: nicotine, varenicline (partial agonist)
Muscarinic & nicotinic: acetylcholine
Does acetylcholine cross membranes or BBB?
No, it is a quaternary ammonium
MOA and uses of pilocarpine
- Alkaloid nonselective muscarinic acetylcholine receptor agonist
- M3 receptor activation
- Treatment of glaucoma (both narrow- and wide-angle) by freeing entrance to Schlemm’ canal for narrow-angle and enhancing tone of the trabecular meshwork for wide-angle
- Treatment of xerostomia (dry mouth) by promoting salivation
Adverse / side effects of pilocarpine
- topical ophthalmic administration → minimal systemic absorption but local stinging and irritation
- oral administration → sweating, blurred vision, and other cholinergic adverse effects + worsens asthma and COPD
MOA and uses of bethanechol
- quaternary choline ester muscarinic acetylcholine receptor agonist (M3)
- GU: increase detrusor tone and decrease outlet resistance of internal sphincter
- GI: increase motility and secretion
- weak agonist at M2 → minimal cardiac effects
- crosses BBB poorly → minimal CNS effects - Treatment of gastric atony by increasing motility and secretion in the GI
- Treatment of urinary retention by increasing detrusor tone and decreasing outlet resistance of internal sphincter
Adverse / side effects of bethanechol
- pulmonary: bronchoconstriction, increase secretions
- GI: nausea, vomiting cramps and diarrhoea
- ophthalmic: miosis
Contraindicated in asthma!
MOA & uses of nicotine
- Nm (neuromuscular) nicotinic acetylcholine receptor agonist
- Skeletal muscle contraction, fasciculations, spasms
- High dose → depolarising blockade - Nn (neuronal) nicotinic acetylcholine receptor agonist
- Adrenal medulla: adrenaline release
- Cardiac: increase HR
- Vascular: peripheral vasoconstriction
- GI: increase gut motility, increase secretions
- Carotid bodies: increase RR
- medullary emetic chemoreceptors: nausea & vomiting - Clinical uses: aid to smoking cessation
Adverse / side effects of nicotine
- dependence due to activation of brain dopaminergic reward pathways
- low dose: increase HR, RR, BP, decrease appetite
- high dose: medullary depression, bradycardia, neuromuscular blockade
MOA & uses of varenicline
- partial nicotinic agonist
2. highly effective in smoking cessation
Adverse / side effects of varenicline
associated with psychiatric symptoms, including suicide ideation
Types of indirect cholinergic drugs
- Acetylcholinesterase (AChE) inhibitors
2. Low does nicotine
MOA of AChE inhibitors
Increase the availability of acetylcholine
Classification of AChE inhibitors
- Reversible
- Short acting: Edrophonium
- Long-acting: Neostigmine, Pyridostigmine, Physostigmine (carbamates) + Donepezil - Irreversible or poorly reversible
- Very long-acting: Sarin, malathion, parathion
MOA and uses of donepezil / physostigmine
- noncovalent acetylcholine esterase inhibitor
- crosses BBB readily (in contrast to neostigmine)
- physostigmine: carbamate AChE inhibitor that is tertiary amine → crosses BBB readily
- clinical use for donepezil → produces modest cognitive improvement → Alzheimer’s disease
- clinical use for physostigmine → antidote for atropine poisoning
Adverse/side effects of donepezil / physostigmine
diarrhoea, nausea, vomiting and other common cholinergic side effects
MOA & uses of neostigmine
- carbamate inhibitor of AChE
- M3: contracts GI and GU smooth muscles, decreases sphincter tone and increase secretions
- clinical uses for neostigmine:
- reversal of nondepolarising neuromuscular blockade
- myasthenia graves
- increase GI motility on post op or neurogenic ileus
- treatment of urinary retention secondary to bladder atony
Adverse/side effects of neostigmine
- peripheral cholinergic adverse effects: diarrhoea, sweating, urinary urgency
- quaternary carbamate: poor absorption, do not penetrate into CSF
MOA of sarin, parathion, malathion
potent suicide inhibitor of AChE → increase ACh at NM and neuronal synapses
Clinical manifestation of sarin acute poisoning
Cholinergic crisis: SLUD S - Salivation L - Lacrimation U - Urination D - Defecation
+ abdominal cramps, miosis, hypotension, bradycardia
Antidote for sarin acute poisoning
- Cholinesterase regenerator: Pralidoxime
2. mACh receptor blockers: Atropine
MOA / uses for Pralidoxime
- cholinesterase regenerator
- higher affinity for phosphate than AChE
- clinical use: acute treatment of organophosphate poisoning
Limitations of pralidoxime
- Must be administered within a few hours before “ageing” occurs
- Only effective in organophosphate poisoning
- Not effective if AChE is carbamylated (e.g. by neostigmine)
Types of direct anticholinergic drugs
- Receptor antagonists:
- Muscarininc: atropine, benzatropine, scopolamine, ipratropium, oxybutynin
- Non-depolarising neuromuscular blocking agents (NMBAs) - Ganglionic blockers:
High dose nicotine
Adverse effects of anticholinergic drugs
blurred vision, confusion, mydriasis, constipation, urinary retention
MOA / uses of atropine
- nonselective muscarinic acetylcholine receptor antagonist
- M1 block → decrease gastric acid secretion; CNS confusion/delirium
- M2 block → increase HR
- M3 block → decrease saliva, decrease bronchial secretions; decrease sweat; mydriasis; cycloplegia; inhibit micturition; decrease GI tone and motility; decrease GI secretions
- M4/M5 block → contribute to CNS effects - treatment of bradycardia
- treatment of anti cholinesterase overdose
- GI antimotility agent to treat diarrhoea (with diphenoxylate)
- for ophthalmic examination - cycloplegia and mydriasis
Adverse / side effects / contraindications of atropine
“red as a beet, blind as a bat, dry as a bone, hot as a hare, and mad as a hatter”
- red as a beet → superficial vasodilation
- blind as a bat → blurred vision
- dry as a bone → decrease secretions
- hot as a hare → hyperthermia (decrease sweat)
- mad as a hatter → delirium and hallucinations
Contraindicated in narrow-angle glaucoma!
MOA / uses of benzatropine
- Nonselective muscarinic acetylcholine receptor antagonist
- Tertiary amine alkaloid → crosses the BBB better and has stronger CNS effects
- dopaminergic-cholinergic balance in striatum
- treatment of Parkinson’s disease and Parkinsonism
Adverse / side effects / contraindications of benzatropine
hyperthermia (decrease sweat), glaucoma, urinary retention, dry mouth, constipation, blurred vision, sedation, amnesia, delirium, hallucinations
Contraindicated in narrow-angle glaucoma!
MOA / uses of scopolamine
- Nonselective muscarinic acetylcholine receptor antagonist
- M3 block → inhibits secretions and relaxes smooth muscles
- M2 block → tachycardia
- CNS → antiemetic and amnesic - treatment of motion sickness, urinary incontinence, adjunct for anaesthesia (amnesia, decrease secretions, decrease nausea)
Adverse / side effects / contraindications of scopolamine
dry mouth, constipation, urinary retention, blurred vision, sedation, glaucoma
Contraindicated in narrow-angle glaucoma!
MOA / uses of ipratropium
- Nonselective muscarinic acetylcholine receptor antagonist
- M3 block → decrease bronchoconstriction and decrease bronchial secretions - Quaternary amine → poorly absorbed systematically and minimal CNS effects
- treatment of COPD (1st line therapy) & asthma (via inhalation as a 2nd line therapy)
Side effects of ipratropium
- minimal due to poor systemic absorption
- dry mouth
- sedation (administration with bromide which can cross BBB to cause sedation)
- bradycardia (rarely)
MOA / uses of oxybutynin
- Nonselective muscarinic acetylcholine receptor antagonist
- M3 block → relaxes smooth muscle walls, increase sphincter tone and decrease secretions
- M1 block → decease gastric acid production (via action on enterochromaffin-like cells) - tertiary amine
- treatment for urinary incontinence
- reduction of gastric acid secretion and treatment of peptic ulcer (better tolerated drugs are used for this indication)
Adverse effects / side effects/ contraindications of oxybutynin
Parasympatholytic effects: mydriasis (pupillary dilation), tachycardia, decrease GI motility, decrease secretions
Contraindications:
- pyloric obstruction; retentive bladder
- narrow-angle glaucoma
What are non-depolarising NMBAs?
- Block Nm nicotinic ACh receptors
- Block neurotransmission at Nm junctions
- Paralysis of skeletal muscles
Characteristics of non-depolarising NMBAs
- Poor oral absorption
- Low lipid solubility → do not penetrate BBB
- Small Vd
Types of non-depolarising NMBAs
Short-acting: Rocuronium (0.5-3mins)
Intermediate-acting: Pancurorium, Atracurium (2-5mins)
Long-acting: Tubocurarine (2-13mins)
MOA & uses of Pancuronium
- competitive antagonists of Nm nicotinic acetylcholine receptor
- non-depolarising blockade results in skeletal muscle paralysis
- IV → rapid onset of action and short half-life
- clinical uses: indication of paralysis for surgery
Side effects of pancuronium
- Histamine release at higher doses: flushing, oedema, erythema, hypotension, tachycardia
- Weak antimuscarinic activity: increase HR, increase CO due to vagolytic effects
Types of indirect anticholinergic drugs
- depolarising neuromuscular blocking agents (NMBAs): succinylcholine
- presynaptic toxin: botulinum toxin
MOA and uses of succinylcholine
- Nm nicotinic acetylcholine receptor agonist
Phase 1 → opens sodium channels associated with nAChR → depolarisation → fasciculations
Phase 2 → continuous depolarisation → gradual repolarisation as the sodium channels close or is blocked → resistance to depolarisation → flaccid paralysis (depolarising blockade) - clinical use: paralysis for brief surgical procedures
Adverse effects of succinylcholine
- Malignant hyperthermia
- Apnea
- Hypotension, arrhythmias, respiratory collapse
MOA and uses of botulinum toxin
- Cleaves SNARE proteins preventing exocytosis of ACh containing synaptic vesicles
- clincial uses: cervical dystonia, blepharospasm, strabismus, migraine and other headache disorders, upper limb spasticity
Side effects of botulinum toxin
- paralysis of wrong muscle group
2. allergic reactions